Cargando…

Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population

INTRODUCTION: Hearing impairment (HI) is characterized by complex genetic heterogeneity. The evolution of next generation sequencing, including targeted enrichment panels, has revolutionized HI diagnosis. OBJECTIVES: In this study, we investigated genetic causes in 22 individuals with non-GJB2 HI. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Souissi, Amal, Ben Said, Mariem, Ben Ayed, Ikhlas, Elloumi, Ines, Bouzid, Amal, Mosrati, Mohamed Ali, Hasnaoui, Mehdi, Belcadhi, Malek, Idriss, Nabil, Kamoun, Hassen, Gharbi, Nourhene, Gibriel, Abdullah A., Tlili, Abdelaziz, Masmoudi, Saber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240103/
https://www.ncbi.nlm.nih.gov/pubmed/34194829
http://dx.doi.org/10.1016/j.jare.2021.01.005
_version_ 1783715149285163008
author Souissi, Amal
Ben Said, Mariem
Ben Ayed, Ikhlas
Elloumi, Ines
Bouzid, Amal
Mosrati, Mohamed Ali
Hasnaoui, Mehdi
Belcadhi, Malek
Idriss, Nabil
Kamoun, Hassen
Gharbi, Nourhene
Gibriel, Abdullah A.
Tlili, Abdelaziz
Masmoudi, Saber
author_facet Souissi, Amal
Ben Said, Mariem
Ben Ayed, Ikhlas
Elloumi, Ines
Bouzid, Amal
Mosrati, Mohamed Ali
Hasnaoui, Mehdi
Belcadhi, Malek
Idriss, Nabil
Kamoun, Hassen
Gharbi, Nourhene
Gibriel, Abdullah A.
Tlili, Abdelaziz
Masmoudi, Saber
author_sort Souissi, Amal
collection PubMed
description INTRODUCTION: Hearing impairment (HI) is characterized by complex genetic heterogeneity. The evolution of next generation sequencing, including targeted enrichment panels, has revolutionized HI diagnosis. OBJECTIVES: In this study, we investigated genetic causes in 22 individuals with non-GJB2 HI. METHODS: We customized a Haloplex(HS) kit to include 30 genes known to be associated with autosomal recessive nonsyndromic HI (ARNSHI) and Usher syndrome in North Africa. RESULTS: In accordance with the ACMG/AMP guidelines, we report 11 pathogenic variants; as follows; five novel variants including three missense (ESRRB-Tyr295Cys, MYO15A-Phe2089Leu and MYO7A-Tyr560Cys) and two nonsense (USH1C-Gln122Ter and CIB2-Arg104Ter) mutations; two previously reported mutations (OTOF-Glu57Ter and PNPT1-Glu475Gly), but first time identified among Tunisian families; and four other identified mutations namely WHRN-Gly808AspfsX11, SLC22A4-Cys113Tyr and two MYO7A compound heterozygous splice site variants that were previously described in Tunisia. Pathogenic variants in WHRN and CIB2 genes, in patients with convincing phenotype ruling out retinitis pigmentosa, provide strong evidence supporting their association with ARNSHI. Moreover, we shed lights on the pathogenic implication of mutations in PNPT1 gene in auditory function providing new evidence for its association with ARNSHI. Lack of segregation of a previously identified causal mutation OTOA-Val603Phe further supports its classification as variant of unknown significance. Our study reports absence of otoacoustic emission in subjects using bilateral hearing aids for several years indicating the importance of screening genetic alteration in OTOF gene for proper management of those patients. CONCLUSION: In conclusion, our findings do not only expand the spectrum of HI mutations in Tunisian patients, but also improve our knowledge about clinical relevance of HI causing genes and variants.
format Online
Article
Text
id pubmed-8240103
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82401032021-06-29 Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population Souissi, Amal Ben Said, Mariem Ben Ayed, Ikhlas Elloumi, Ines Bouzid, Amal Mosrati, Mohamed Ali Hasnaoui, Mehdi Belcadhi, Malek Idriss, Nabil Kamoun, Hassen Gharbi, Nourhene Gibriel, Abdullah A. Tlili, Abdelaziz Masmoudi, Saber J Adv Res Medicine INTRODUCTION: Hearing impairment (HI) is characterized by complex genetic heterogeneity. The evolution of next generation sequencing, including targeted enrichment panels, has revolutionized HI diagnosis. OBJECTIVES: In this study, we investigated genetic causes in 22 individuals with non-GJB2 HI. METHODS: We customized a Haloplex(HS) kit to include 30 genes known to be associated with autosomal recessive nonsyndromic HI (ARNSHI) and Usher syndrome in North Africa. RESULTS: In accordance with the ACMG/AMP guidelines, we report 11 pathogenic variants; as follows; five novel variants including three missense (ESRRB-Tyr295Cys, MYO15A-Phe2089Leu and MYO7A-Tyr560Cys) and two nonsense (USH1C-Gln122Ter and CIB2-Arg104Ter) mutations; two previously reported mutations (OTOF-Glu57Ter and PNPT1-Glu475Gly), but first time identified among Tunisian families; and four other identified mutations namely WHRN-Gly808AspfsX11, SLC22A4-Cys113Tyr and two MYO7A compound heterozygous splice site variants that were previously described in Tunisia. Pathogenic variants in WHRN and CIB2 genes, in patients with convincing phenotype ruling out retinitis pigmentosa, provide strong evidence supporting their association with ARNSHI. Moreover, we shed lights on the pathogenic implication of mutations in PNPT1 gene in auditory function providing new evidence for its association with ARNSHI. Lack of segregation of a previously identified causal mutation OTOA-Val603Phe further supports its classification as variant of unknown significance. Our study reports absence of otoacoustic emission in subjects using bilateral hearing aids for several years indicating the importance of screening genetic alteration in OTOF gene for proper management of those patients. CONCLUSION: In conclusion, our findings do not only expand the spectrum of HI mutations in Tunisian patients, but also improve our knowledge about clinical relevance of HI causing genes and variants. Elsevier 2021-01-12 /pmc/articles/PMC8240103/ /pubmed/34194829 http://dx.doi.org/10.1016/j.jare.2021.01.005 Text en © 2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Medicine
Souissi, Amal
Ben Said, Mariem
Ben Ayed, Ikhlas
Elloumi, Ines
Bouzid, Amal
Mosrati, Mohamed Ali
Hasnaoui, Mehdi
Belcadhi, Malek
Idriss, Nabil
Kamoun, Hassen
Gharbi, Nourhene
Gibriel, Abdullah A.
Tlili, Abdelaziz
Masmoudi, Saber
Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population
title Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population
title_full Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population
title_fullStr Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population
title_full_unstemmed Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population
title_short Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population
title_sort novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in tunisian population
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240103/
https://www.ncbi.nlm.nih.gov/pubmed/34194829
http://dx.doi.org/10.1016/j.jare.2021.01.005
work_keys_str_mv AT souissiamal novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT bensaidmariem novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT benayedikhlas novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT elloumiines novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT bouzidamal novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT mosratimohamedali novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT hasnaouimehdi novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT belcadhimalek novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT idrissnabil novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT kamounhassen novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT gharbinourhene novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT gibrielabdullaha novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT tliliabdelaziz novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation
AT masmoudisaber novelpathogenicmutationsandfurtherevidenceforclinicalrelevanceofgenesandvariantscausinghearingimpairmentintunisianpopulation